METHOD FOR PREVENTING SEVERE PREGNANCY COMPLICATIONS IN THROMBOPHILIC PATIENTS Russian patent published in 2009 - IPC A61K31/716 A61P7/02 A61P15/00 

FIELD: medicine.

SUBSTANCE: to prevent severe pregnancy complications in thrombopillic patients, 1-2 months prior to planned pregnancy, preparation VESSEL DUE F is introduced in a dose 1000 units/day - 2 tablets twice a day to ensure decrease in lupus anticoagulant (LA) activity by at least 0.8. Then onset of pregnancy follows. During the first pregnancy trimester, VESSEL DUE F is substituted for Clexane injected in abdomen subcutaneously in a dose 0.4 ml/day daily. Starting from thirteenth week of pregnancy, VESSEL DUE F therapy is recommenced in a previous dose - 2 tablets twice a day until delivery. Introduction of VESSEL DUE F is prolonged continue within the first postpartum month.

EFFECT: integrated effect on all the links of haemostasis system, prolonged intake of tableted formulation without side effects on a foetus during pregnancy and lactation.

2 ex